Different domains of the glucagon and glucagon‐like peptide‐1 receptors provide the critical determinants of ligand selectivity
S. Runge(Novo Nordisk (Denmark)), Lotte Bjerre Knudsen(Novo Nordisk (Denmark)), Kjeld Madsen(Novo Nordisk (Denmark)), Birgitte S. Wulff(Novo Nordisk (Denmark)), Hans Bräuner‐Osborne(University of Copenhagen)
Cited by 132
Related Papers
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
|Journal of Clinical Investigation|2014|913
The Discovery and Development of Liraglutide and Semaglutide
|Frontiers in Endocrinology|2019|890
Semaglutide lowers body weight in rodents via distributed neural pathways
|JCI Insight|2020|664
Ligands for Glutamate Receptors: Design and Therapeutic Prospects
|Journal of Medicinal Chemistry|2000|525
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488